Operating Income (Loss) in USD of BioAtla, Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BioAtla, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2019 to Q3 2025.
  • BioAtla, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$13.8M, a 22.4% decline year-over-year.
  • BioAtla, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$66.3M, a 23.1% increase year-over-year.
  • BioAtla, Inc. annual Operating Income (Loss) for 2024 was -$73.9M, a 43% increase from 2023.
  • BioAtla, Inc. annual Operating Income (Loss) for 2023 was -$130M, a 19.9% decline from 2022.
  • BioAtla, Inc. annual Operating Income (Loss) for 2022 was -$108M, a 12.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

BioAtla, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$66.3M -$13.8M -$2.52M -22.4% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 -$63.8M -$18.6M +$3.33M +15.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$67.1M -$17.6M +$6.84M +28% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 -$73.9M -$16.2M +$12.3M +43.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 -$86.2M -$11.3M +$23.8M +67.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 -$110M -$22M +$15.2M +40.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$125M -$24.5M +$4.47M +15.5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 -$130M -$28.5M +$24K +0.08% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 -$130M -$35M -$8.84M -33.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$121M -$37.2M -$8.15M -28% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$113M -$28.9M -$4.58M -18.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$108M -$28.6M -$5.07M -21.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$103M -$26.2M -$2.48M -10.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$101M -$29.1M +$1.41M +4.61% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$102M -$24.3M -$5.55M -29.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$96.4M -$23.5M -$7.03M -42.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$89.4M -$23.7M -$15.7M -196% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$73.7M -$30.5M -$25.9M -574% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$47.8M -$18.8M -$17.7M -1595% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$30.1M -$16.5M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$8.02M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$4.52M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$1.11M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12

BioAtla, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$73.9M +$55.7M +43% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 -$130M -$21.5M -19.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 -$108M -$11.7M -12.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 -$96.4M -$66.3M -220% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$30.1M -$1.83M -6.48% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 -$28.3M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.